Quinidine: potent inhibition of sparteine and debrisoquine oxidation in vivo. (Q34447859)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3756068%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

title

Quinidine: potent inhibition of sparteine and debrisoquine oxidation in vivo (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3756068%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3756068%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

author name string

T Inaba

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3756068%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

W A Mahon

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3756068%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

language of work or name

English

0 references

publication date

1 August 1986

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3756068%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Clinical Pharmacology

4 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3756068%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3756068%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3756068%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

page(s)

199-200

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3756068%20AND%20SRC:MED&resulttype=core&format=json

Polymorphic drug oxidation in humans

4 October 2019

cites work

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401106

Oxidation phenotype and the metabolism and action of beta-blockers

6 July 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401106

Competitive inhibition of sparteine oxidation in human liver by β-adrenoceptor antagonists and other cardiovascular drugs

6 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1986.TB05251.X

In vitro inhibition studies of two isozymes of human liver cytochrome P-450. Mephenytoin p-hydroxylase and sparteine monooxygenase

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3756068

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Comparative pharmacogenetics of sparteine and debrisoquine

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3756068

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1365-2125.1986.TB05251.X

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3756068%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3756068%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

PubMed publication ID

3756068

1 reference